Related Experiment Video
Updated: Mar 22, 2026
07:13
Early Detection of Cyanobacterial Blooms and Associated Cyanotoxins using Fast Detection Strategy
Published on: February 25, 2021
4.6K
Deaths by poisoning in Norway 2003-2012
Jartrud Wigen Skjerdal1, Erik Andrew2, Finn Gjertsen3
1a Poisons Information Center , Norwegian Institute of Public Health , Oslo , Norway ;
Clinical Toxicology (Philadelphia, Pa.)
|April 20, 2016
Summary
Poisoning deaths in Norway decreased from 2003 to 2012, with opioids like heroin and methadone being significant factors. Continued monitoring of poisoning trends is crucial for public health.
Area of Science:
- Public Health
- Toxicology
- Epidemiology
Background:
- Poisoning represents a significant and preventable cause of mortality in Norway.
- Effective public health strategies necessitate close surveillance of poisoning trends.
Purpose of the Study:
- To analyze the patterns and temporal trends of poisoning-related mortality in Norway.
- The study period spans from 2003 to 2012, utilizing official mortality data.
Main Methods:
- A population-based registry study design was employed.
- Analysis included underlying external causes of death for poisoning (ICD-10 codes X40-Y19).
- Poisson regression was used to estimate mortality trends, with comparisons to other injury mechanisms.
Main Results:
- Poisoning was the second leading cause of injury deaths in Norway (2003-2012), with 424-496 annual fatalities.
- Accidental poisonings accounted for the majority (3366/4620) of deaths.
- Opioids were the primary agents; heroin deaths decreased, while methadone-related fatalities increased.
Conclusions:
- Poisoning mortality rates in Norway showed a decline between 2003 and 2012.
- Data interpretation requires caution due to potential international data collection differences.
- Emphasis on evaluating preventive measures and monitoring methadone-related deaths is recommended.
Related Concept Videos
01:26Pharmaceutical Poisoning: Potential Scenarios
74
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
74
01:26Pharmaceutical Poisoning: Treatment Strategies
141
Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
141
01:14Prevention of Further Absorption of Poison
1.4K
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
1.4K
01:26Anticholinesterase Agents: Poisoning and Treatment
1.9K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.9K
01:30Toxidromes: Clinical Features
114
Toxidromes are specific patterns of symptoms resulting from toxic substance exposure. They help in the identification and treatment of poisoning. The symptoms of each toxidrome group indicate poisoning by a certain class of chemicals or drugs.1. Sympathomimetic: Stimulates the sympathetic nervous system. Symptoms include agitation, increased heart rate (HR), blood pressure (BP), respiratory rate (RR), temperature, and pupil size. Drugs like cocaine and amphetamines, along with tremors and...
114
01:26Enhanced Elimination of Poison
1.0K
Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
1.0K